These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4090 related articles for article (PubMed ID: 6497401)
1. [Control of multiple skin and lung metastasis of malignant melanoma by combined DAV and OK-432 chemoimmunotherapy in association with large-scale administration of indomethacin]. Maeda K; Miura S; Kawamura M; Jimbow K Gan To Kagaku Ryoho; 1984 Nov; 11(11):2434-7. PubMed ID: 6497401 [TBL] [Abstract][Full Text] [Related]
2. [Case of metastatic malignant melanoma responded to combination chemotherapy with DTIC]. Tamura T; Miyamoto H; Harada M; Makinoya T; Yamamoto M; Miyoshi Y; Komi N Gan To Kagaku Ryoho; 1984 Feb; 11(2):327-32. PubMed ID: 6582806 [TBL] [Abstract][Full Text] [Related]
3. [A case of malignant melanoma responded to chemotherapy including DTIC and local injection of OK-432]. Tsuji H; Sawada S; Okano R; Shimazaki C; Nakanishi S; Haruyama H; Isemura T; Nakagawa M; Ijichi H; Ueda K Gan To Kagaku Ryoho; 1982 Oct; 9(10):1851-5. PubMed ID: 6964031 [TBL] [Abstract][Full Text] [Related]
4. [Malignant melanoma in Japan: unique distribution and effect of DAV chemoimmunotherapy (part II)]. Ishihara K; Hayasaka K; Ikeda S; Terakado T; Kukita A; Seki Y; Jimbow K; Suzuki M Gan To Kagaku Ryoho; 1984 Mar; 11(3):467-73. PubMed ID: 6703721 [TBL] [Abstract][Full Text] [Related]
5. [Malignant melanoma in Japan: unique distribution and effect of DAV chemoimmunotherapy]. Jimbow K; Takahashi H; Ishihara K; Hayasaka K; Kukita A; Seki Y; Ikeda S; Terakado T Gan To Kagaku Ryoho; 1982 Nov; 9(11):1942-9. PubMed ID: 7184382 [TBL] [Abstract][Full Text] [Related]
6. [Chemotherapy of malignant melanoma]. Ishihara K; Yamazaki N; Asano K Gan To Kagaku Ryoho; 1993 Aug; 20(10):1287-92. PubMed ID: 7688498 [TBL] [Abstract][Full Text] [Related]
7. Changes in immunological parameters after combination adjuvant therapy with intravenous DTIC, ACNU, and VCR, and local injection of IFN-beta (DAV + IFN-beta therapy) into malignant melanoma. Umeda T; Aoki K; Yokoyama A; Ohara H; Hayashi O; Tanaka K; Nishioka K J Dermatol; 1998 Sep; 25(9):569-72. PubMed ID: 9798342 [TBL] [Abstract][Full Text] [Related]
8. [An autopsy case of neurocutaneous melanosis associated with intracerebral malignant melanoma]. Sawamura Y; Abe H; Murai H; Tashiro K; Doi S No To Shinkei; 1987 Aug; 39(8):789-95. PubMed ID: 3322333 [TBL] [Abstract][Full Text] [Related]
9. [Chemotherapy of malignant melanoma]. Ishihara K Gan To Kagaku Ryoho; 1995 Jan; 22(1):23-7. PubMed ID: 7529980 [TBL] [Abstract][Full Text] [Related]
10. [Therapeutic response of interferon-beta in malignant melanoma]. Ishihara K Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1010-6. PubMed ID: 2421645 [TBL] [Abstract][Full Text] [Related]
11. [Diagnosis and treatment of malignant melanoma]. Ishihara K; Ikegawa S Gan To Kagaku Ryoho; 1985 Sep; 12(9):1727-34. PubMed ID: 2412493 [TBL] [Abstract][Full Text] [Related]
12. [New combination chemotherapy for malignant melanoma--PAV(peplomycin, ACNU, VCR) therapy]. Ikeda S; Tajima K; Miyasato H; Terakado T; Suzuki T; Miura T Gan To Kagaku Ryoho; 1983 Oct; 10(10):2198-204. PubMed ID: 6194756 [TBL] [Abstract][Full Text] [Related]
13. [Marked regression of melanoma metastases under combined chemotherapy]. Klemm-Mayer H; Rasokat H; Wagner G Z Hautkr; 1984 Apr; 59(7):443-5. PubMed ID: 6730608 [TBL] [Abstract][Full Text] [Related]
14. [Adjuvant chemotherapy of malignant melanoma of the female genital organs]. Inoue S; Shibata S; Tohya T; Munemura M; Fujisaki S; Maeyama M Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jan; 38(1):135-8. PubMed ID: 3456398 [No Abstract] [Full Text] [Related]
15. Local injection of interferon beta in malignant melanoma of the esophagus as adjuvant of systemic pre- and postoperative DAV chemotherapy: case report with 7 years of long-term survival. Kawada K; Kawano T; Nagai K; Nishikage T; Nakajima Y; Tokairin Y; Ogiya K; Tanaka K; Iwai T Gastrointest Endosc; 2007 Aug; 66(2):408-10. PubMed ID: 17643724 [No Abstract] [Full Text] [Related]
16. The course of melanoma-associated vitiligo: report of a case. Daneshpazhooh M; Shokoohi A; Dadban A; Raafat J Melanoma Res; 2006 Aug; 16(4):371-3. PubMed ID: 16845334 [TBL] [Abstract][Full Text] [Related]
17. Treatment and prognosis of malignant melanoma of the oral cavity: preoperative surgical procedure increases risk of distant metastasis. Umeda M; Komatsubara H; Shigeta T; Ojima Y; Minamikawa T; Shibuya Y; Yokoo S; Komori T Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Jul; 106(1):51-7. PubMed ID: 18504155 [TBL] [Abstract][Full Text] [Related]
18. [A combination chemotherapy of ACNU and DTIC for advanced malignant melanoma]. Domyo M; Ogawa M; Inagaki J; Horikoshi N; Ezaki K; Inoue K; Aiba K; Nagata T; Miyamoto H Gan To Kagaku Ryoho; 1982 May; 9(5):874-9. PubMed ID: 6964041 [TBL] [Abstract][Full Text] [Related]
19. The use of DAV (DTIC, ACNU and VCR) and natural interferon-beta combination therapy in malignant melanoma. Nagatani T; Ichiyama S; Onuma R; Miyazawa M; Matsuzaki T; Miyagawa K; Baba N; Uchiyama M; Nakajima H Acta Derm Venereol; 1995 Nov; 75(6):494. PubMed ID: 8651034 [No Abstract] [Full Text] [Related]
20. [Results of a randomized polychemotherapy study in malignant melanoma]. Fiedler H; Hetschko I; Wohlrab W; Wozniak KD; Lübbe D; Taube KM Hautarzt; 1990 Jul; 41(7):369-74. PubMed ID: 1698185 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]